baber/WOPTO huggingface dataset:
Patent CA-2578773-A1 (CA)
Title: Force control strut
Inventor: ADOLINE JACK W
IPC: F16F3/04
Filed: 2007-02-16
Abstract: A force control strut comprising an elongated housing having a straight guide tube with an inner surface, a rod member having an inner end reciprocally movable along the guide tube and an outer end extending outwardly from the housing, a guide member secured into the first end of the housing to form a bushing allowing reciprocation of the rod member between a retracted position and an extended position and a bottom plug fixed to the second end of the housing. A guide piston is secured to the inner end of the rod and is slidable along the inner surface of the housing. A coil spring is located between the piston and one end of the housing to bias the rod in a given direction in the housing. There is a damper mechanism combined with the movable rod and including a plunger reciprocally mounted in an elongated force controlling passageway inside the rod. The plunger is movable outwardly from the rod and has a distal end engageable with the bottom plug to force the plunger intro the force controlling passageway to dampen movement of the rod in the housing.
Patent CA-2578815-A1 (CA)
Inventor: EPSTEIN STEPHEN E
IPC: A61K35/28
Filed: 2005-09-07
Abstract: A therapeutic composition is provided that comprises a cell-free conditioned medium containing mixed secretion products of isolated angiogenic progenitor cells obtained from bone marrow, peripheral blood, or adipose tissue. The composition may additionally contain angiogenesis-promoting proteins obtained by transfecting the progenitors cells in culture with an angiogenesis promoting transgene. The composition is useful to promote angiogenesis when introduced into or adjacent to an ischemic site in a patient, such as in myocardium or peripheral limb. Methods are also provided for utilizing such cell-free conditioned medium to deliver angiogenesis-promoting proteins to a patient. The cell-free conditioned medium can also be injected into the blood stream for delivery to the ischemic tissue. The cells can derive from either an autologous or allogenic source and can be lyophilized or frozen for storage.
Patent CA-2580448-A1 (CA)
Title: Use of [d-meala]3-[etval]4-cyclosporin for the treatment of hepatitis c infection and pharmaceutical composition comprising said [d-meala]3-[etval]4-cyclosporin
Inventor: DUMONT JEAN-MAURICE
IPC: A61K38/13
Filed: 2005-10-03
Abstract: This invention relates to the use in the treatment of HCV infection, either as single active agents or in combination with another active agent, of a cyclosporin having increased cyclophilin binding activity and essentially lacking immunosuppressive activity.
Patent CA-2581245-A1 (CA)
Title: Mold clamping device
Inventor: MORITANI KOUJI
IPC: B29C45/66
Filed: 2005-09-27
Abstract: A mold clamping device whose axial dimension can be reduced. The mold clamping device has a first fixed member (11) on which a fixed mold (15) is installed, a first movable member (12) placed so as to face the first fixed member (11) and on which a movable mold (16) is installed, a second movable member (22) moved as the first movable member (12) is advanced and retreated, a mold clamping force transmission member (39) for connecting the first and second movable members (12, 22), and a drive section (28) for performing mold opening and closing by advancing and retreating the first movable member (12). The drive section (28) for mold opening and closing and at least a part of the mold clamping force transmission member (39) are overlapped on each other. In this case, because of the overlap, the axial dimension of the mold clamping device (10) can be reduced.
Patent CA-2581744-A1 (CA)
Title: Sliding screen door
Inventor: MORIYA HIROFUMI
IPC: E06B9/58
Filed: 2004-10-07
Abstract: A sliding screen door provided with a net guide being led out along the lower end of a net as it is opened/closed wherein right and left opening/closing directions of the net in the sliding screen door can be reversed. The sliding net (6) is fixed between the first jamb member (2) in the sliding screen door (1) and a movable door frame (5) for open/close operation such that a net guide (10) for guiding the lower end advances/retracts as the net is opened/closed. The first jamb member (2) and the movable door frame (5) are shaped substantially symmetrically in the vertical direction along with the net (6) being fixed between them, and right and left opening/closing directions of the net can be reversed by reversing them vertically without reversing the front and rear. As they are reversed vertically, the net guide is fixed selectively to one of fixing portions (19) provided at the opposite ends of the first jamb member (2) for securing one end of the net guide (10) and fixing position of the net guide can be altered.
Patent CA-2582836-A1 (CA)
Title: Apparatus and method for calculating work load engine
Inventor: YASUI YUJI
IPC: F02D45/00
Filed: 2005-09-28
Abstract: A device and method for calculating the work load of an engine more efficiently and accurately. The device for calculating the work load of an engine comprises a means for determining a desired frequency component to calculate the work load of the engine obtained through frequency decomposition of the volume variation rate of the engine. The device further comprises a first calculating means for calculating a first correlation coefficient between the volume variation rate and a reference signal composed of a frequency corresponding to the determined component, and a second calculating means for calculating a second correlation coefficient between the cylinder inner pressure of the engine and a reference signal composed of a frequency corresponding to the determined component. The work load of the engine is calculated using the first and second correlation coefficients.
Patent CA-2583308-A1 (CA)
Title: Microencapsulation of cells in hydrogels using electrostatic potentials
Inventor: KINNEY RAMSEY CHRISTIAN
IPC: A61K35/12
Filed: 2005-10-07
Abstract: Compositions and methods for producing encapsulated cells having an average diameter of less than about 200 ~m are provided . Methods for using the disclosed encapsulated cells are also provided
Patent CA-2584488-A1 (CA)
Title: Electronics enclosure and associated mounting apparatus
Inventor: JACKLIN GREGORY P
IPC: F21V15/01
Filed: 2007-04-05
Abstract: An enclosure is arranged for housing electronics associated with a luminaire and includes a first member including a mounting interface arranged to couple the first member to the luminaire and a second member mechanically coupled to the first member.  The mounting interface facilitates provisionally coupling the first member to the luminaire and securing the enclosure to the luminaire. A corresponding mounting apparatus for securing an enclosure to a luminaire includes a mounting member having an opening and configured to be secured to a surface of a luminaire and a neck portion extending from the enclosure and configured to pass through the opening. The neck portion includes a neck opening that is configured to allow wiring to be muted from the electronics to the luminaire. The neck portion and the mounting member may include respective complementary surfaces to provide a mounting interface for provisionally coupling the enclosure to the luminaire.
Patent CA-2585543-A1 (CA)
Title: Concentrate recycle loop with filtration module
Inventor: HAAS WILLIAM E
IPC: C02F1/469
Filed: 2005-10-27
Abstract: Water purification systems include a concentrate filtration membrane (16) and an electrodeionization unit (2). A concentrate effluent stream from the electrodeionization unit (2) is filtered in the concentrate filtration membrane (16); the filtered concentrate effluent stream is provided to concentrating compartments (10) of the electrodeionization unit.
Patent CA-2586389-A1 (CA)
Title: Modified growth hormones
Inventor: DRITTANTI LILA
IPC: C12N15/18
Filed: 2005-11-04
Abstract: Provided are modified growth hormone polypeptides, nucleic acid molecules encoding modified growth hormone polypeptides and methods of generating modified growth hormone polypeptides. Also provided are methods of treatment using modified growth hormone polypeptides.
Patent CA-2588073-A1 (CA)
Title: Isotopically marked quinoline derivatives as adenosin a3 receptor ligands
Inventor: BOER KINGA
IPC: A61K31/435
Filed: 2005-11-09
Abstract: The invention relates to adenozin A3 receptor ligands labeled with iodine isotops of mass number 125, within those favorably to antagonists and their isomers, to the experimental materials containing them, to a process for the preparation of the compounds of the general formula (I) and their isomers, to the new intermediates of the general formula (II) and to the preparation thereof.
Patent CA-2590720-A1 (CA)
Title: Heteroaromatic glucokinase activators
Inventor: KRISTIANSEN MARIT
IPC: A61P3/10
Filed: 2005-12-05
Abstract: The present invention describes 2,3-di-substituted N-heteroaromatic propionamides, of Formula (I) wherein the substitution at the 3-position is an optionally substituted phenyl ring and the substitution at the 2-position is an alkyl or cycloalkyl group; pharmaceutical compositions comprising the same;  and, methods of using the same. The propionamides are glucokinase activators for the treatment of type II diabetes.
Patent CA-2594961-A1 (CA)
Title: Windows having multiple polymer layers
Inventor: KORAN FRANCOIS
IPC: E06B3/66
Filed: 2006-01-18
Abstract: The present invention is in the field of windows having multiple layer polymers disposed thereon, and more specifically, the present invention is in the field of multiple pane windows having multiple layer polymers disposed on one or more panes, the multiple layer polymers comprising a polymer sheet layer and a polymer film.
Patent CA-2596043-A1 (CA)
Title: Easy-type water pressure reducing apparatus
Inventor: LO SHUN-NAN
IPC: F16K1/32
Filed: 2007-08-02
Abstract: An easy-type water pressure reducing apparatus comprises a connecting tube having a bore extending through an inlet end and an outlet end. The bore has an annular seat with a smaller-diameter inlet chamber integrally extending at both sides to which a movable element with an inlet port to receive a spring element is mounted. The movable element also includes positioning guide blocks to fit to water-guiding vents of the inlet chamber, and a ringed groove with a sealing ring to abut tight against the inlet chamber, forming a back-and-forth movable positioning space there-between. Therefore, when water pressure at the outlet end is larger than that at the inlet end, water flow blocked by a water plug of the movable element will push the movable element towards the inlet end, compressing the spring element and closing the water-guiding vents gradually to reduce the water flow and stabilize the water pressure thereby.
Patent CA-2596580-A1 (CA)
Title: System and apparatus for sealing a fracturing head to a wellhead
Inventor: CHEREWYK BORIS BRUCE P
IPC: E21B33/03
Filed: 2007-08-08
Abstract: A wear-resistant sealing system for introducing fracturing fluids to a wellhead comprising a tubular connector having a retaining shoulder and bridging a flange interface created between a frachead and a lower tubular structure. The tubular connector has upper and lower sealing elements above and below the flange interface and forms a contiguous bore for fluid communication of the fracturing fluids from the frachead to the lower tubular structure and wellhead.
Patent CA-2596889-A1 (CA)
Inventor: RIEGEL ULRICH
IPC: A61L15/16
Filed: 2006-01-23
Abstract: The present invention relates to an absorbent structure suitable in, or being an adult or infant dia-per or feminine hygiene article, comprising a water-absorbing material comprising water-absorbing particles that comprise a film coating, comprising an elastic film-forming polymer and a coalescing agent.  The invention also relates to an absorbent structure comprising a water absorbent material obtainable by a process of: a) spray-coating water-absorbing polymeric particles with an elastic film-forming polymer in a fluidized bed reactor at a temperature in the range from 0~C to 150~C and b) heat-treatment of the coated polymeric particles at a temperature above 50~C, wherein in step a) and/or b) a coalescing agent is added.
Patent CA-2597302-A1 (CA)
Title: Methods and apparatus for treatment of luminal hyperplasia
Inventor: GONZALES GILBERT R
IPC: A61B19/00
Filed: 2006-02-10
Abstract: A luminal implant comprises a conversion electron emitting source present on an expandable scaffold. Implant may be positioned within a blood vessel or other luminal site at risk of hyperplasia or neoplasia. The conversion electrons emitted by the source will inhibit hyperplasia or neoplasia.
Patent CA-2599454-A1 (CA)
Title: Activator for peroxisome proliferator activating receptor d
Inventor: SAKUMA SHOGO
IPC: A61K31/4436
Filed: 2006-02-28
Abstract: A compound represented by the general formula (II) or a salt thereof: (II) wherein R11 and R13 independently represent a hydrogen atom, an alkyl group having 1 to 8 carbon atoms, an alkoxy group having 1 to 8 carbon atoms, an alkyl group having 1 to 8 carbon atoms which is substituted by a halogen atom or the like; R12 represents a hydrogen atom, an alkyl group having 1 to 8 carbon atoms, an alkoxy group having 1 to 8 carbon atoms, an alkyl group having 1 to 8 carbon atoms which is substituted by a halogen atom or the like;  R14 and R15 independently represent a hydrogen atom, an alkyl group having 1 to 8 carbon atoms or an alkyl group having 1 to 8 carbon atoms which is substituted by a halogen atom; X1 represents CH or N; Z1 represents an oxygen or sulfur atom; W1 represents an oxygen atom or CH2; and q is an integer of 2 to 4. The compound or salt can be used as an activator for PPAR.delta..
Patent CA-2600407-A1 (CA)
Title: Fibrate compositions containing a surfactant mixture of peg-600 and poloxamer 407
Inventor: LERNER ITZHAK E
IPC: A61K31/216
Filed: 2006-02-13
Abstract: The invention provides at least a composition for the treatment of elevated levels of triglycerides, comprising a therapeutically effective amount of a fibrate drug, preferably fenofibrate, intimately associated with a surfactant mixture, preferably a mixture comprising PGE 6000 and poloxamer 407. The invention also provides a method for the treatment of elevated levels of triglycerides in a subject, comprising administering to the subject the composition.
Patent CA-2601624-A1 (CA)
Inventor: TAKAMI SHIN
IPC: E04B1/38
Filed: 2007-09-13
Abstract: The present invention provides an assistant metal fixture which is excellent in constructability and stability with fixing an external wall, and an external wall constructing structure using the assistant metal fixture. An assistant metal fixture used for fixing an external wall to a skeleton via a securing metal fitting and a heat insulating material placed on a front surface of the skeleton, comprising: a butting fl at plate portion to be butted against a rear surface of the securing metal fitting having an opening in the center area to allow a fixing member to go through, and a first leg unit and a second leg unit erected rearward from the butting flat plate portion, wherein the secon d leg unit is erected from a position closer to the opening than the first leg unit.</SDOA B>
Patent CA-2601721-A1 (CA)
Title: Filled paper and method of manufacturing the same
Inventor: IIJIMA YUKO
IPC: D21H17/69
Filed: 2006-03-16
Abstract: This invention provides a filled paper containing a coated filler prepared by coating a filler with a composite acrylamide copolymer (composite PAM) comprising (A) an anionic polysaccharide and (B) a cationic and/or amphoteric acrylamide copolymer. The composite PAM is prepared, for example, by mixing the component (A) with the component (B). Since the filler is treated with a combination of the components (A) and (B) different from each other in charge properties and structure, suitable coagulation effect can be attained and the coated filler has excellent affinity for pulp slurry. Therefore, even in the case of a highly filled paper, a large paper strengthening effect can be attained by using a small amount of the chemical.
Patent CA-2602238-A1 (CA)
Inventor: LEMMER KARL-HEINZ
IPC: D06M13/332
Filed: 2006-02-25
Abstract: In the case of fiber materials in the form of sheet-like textile structures or yarns, flame-retardant properties can be achieved by applying a polyethylenimine and a phosphonic acid to the fiber materials.
Patent CA-2602599-A1 (CA)
Inventor: TENNENT HOWARD
IPC: D01F9/12
Filed: 2006-03-29
Abstract: Methods of preparing single walled carbon nanotubes are provided. An arrangement comprising one or more layers of fullerene in contact with one side of a metal layer and a solid carbon source in contact with the other side of metal layer is prepared. The fullerene/metal layer/solid carbon source arrangement is then heated to a temperature below where the fullerenes sublime. Single walled carbon nanotubes are grown on the fullerene side of the metal layer.
Patent CA-2603148-A1 (CA)
Title: Supporting inter-technology handover using ieee 802.16 handover procedures
Inventor: SHAHEEN KAMEL M
IPC: H04B7/216
Filed: 2006-03-30
Abstract: A method for performing an inter-technology handover in a wireless communication system in which a mobile subscriber station (MSS) changes base stations (BS) begins by locating one or more target BSs that the MSS can handover to. The technology used by each target BS is identified, and the technology supported by the MSS is determined. A handover of the MSS is performed to a target BS with which the MSS can communicate.
Patent CA-2603496-A1 (CA)
Title: Non-circular stabilization sphere and method
Inventor: ALLARD RANDALL N
IPC: A61F2/46
Filed: 2006-04-03
Abstract: A spacer (10) for inserting between vertebral members. The spacer has a non-spherical shape with an anterior section (20) having a first shape and a posterior section (21) having a different shape. An attachment means (30) is positioned within the posterior section, and may include a receiver for attachment with an insertion device, and an anti-rotation mechanism (32) for assistance in removing the spacer from the insertion device. The non-spherical shape of the spaces provides for alignment within the vertebral space and prevents the attachment mechanism from contacting the vertebral members.  Embodiments of using the spacer is also disclosed which may include inserting the spacer between the vertebral members in a generally posterior approach.  Once inserted, the insertion device acts with the anti-rotation device to remove a connection mechanism from the receiver. The spacer remains between the vertebral members and provides relief to the patient.
Patent CA-2604670-A1 (CA)
Inventor: STRASSENBURG-KLECIAK MAREK
IPC: G06T17/05
Filed: 2007-09-28
Abstract: The present invention relates to a method for inserting at least one graphical object corresponding to one fixture at at least one position in a digital map, comprising the steps of: storing data relating to at least one fixture class in a lookup table, determining at least one position in the digital map, reading the data related to the at least one fix- ture class, generating at least one graphical object representing the at least one fixture based on the data related to the at least one fixture class, assigning the graphical ob- ject to the determined position and displaying the assigned graphical object at the pre- determined position.
Patent CA-2604678-A1 (CA)
Title: Rocker key with led window
Inventor: SOLAR CRISTINA EGEA
IPC: H01H23/04
Filed: 2007-09-27
Abstract: A rocker key with LED window and chromatic cover for actuating electrical mechanisms, including a lower perimeter rim with a rectangular section on an upper and horizontal flat face of which the cover rests. The cover is fitted through pressure on the key in such a way that the key is totally covered thereby and wherein the lower rim of key is uncovered and visible from the outside when the key is elevated according to its normal rocking movement.
Patent CA-2605247-A1 (CA)
Title: Devices and methods for diagnosing or predicting early stage cardiac dysfunctions
Inventor: TRAUTH BERNHARD
IPC: G01N33/68
Filed: 2006-05-03
Abstract: The present invention relates to methods and devices for diagnosing heart failure in a subject based on the amount of Brain natriuretic peptide (BNP) in a urine sample. Moreover, the present invention encompasses methods and devices for predicting whether a subject is at risk of developing cardiovascular events accompanied with heart failure based on the amount of BNP in a urine sample.
Patent CA-2607660-A1 (CA)
Inventor: MISHRA RAJESH KUMAR
IPC: A61K31/421
Filed: 2006-05-08
Abstract: This invention describes the discovery and synthesis of N-thiolated 2-oxazolidinones as a new class of anti bacterial agents. These compounds can be synthesized from 2- oxazolidinones by Ndeprotection and N-sulfenylation. These new substances were found to exhibit potent anti-bacterial activity, including bacteriostatic properties against Staphylococcus spp., including methicillin resistant Staphylcoccus aureus (MRSA), and Bacillus spp., including Bacillus anthracis.
Patent CA-2608092-A1 (CA)
Title: Leukemia disease genes and uses thereof
Inventor: TWINE NATALIE C
IPC: C12Q1/68
Filed: 2006-05-18
Abstract: The invention features the use of whole blood samples or samples comprising peripheral blood mononuclear cells (PBMCs) for diagnosing or evaluating the progression or treatment of leukemia. Genes that are differentially expressed in un-fractionated PBMCs of leukemia patients, as compared to in disease-free humans or in patients who have a differential type of leukemia, can be identified according to the invention. These genes are leukemia disease genes and can be used to detect the presence or progression of leukemia in a subj ect of interest. Leukemias that are amenable to the present invention include, but are not limited to, acute myelogenous leukemia (AML) and myelodysplastic syndromes (MDS). Non- limiting examples of AML or MDS disease genes are provided in Tables 2, 4 and 6.
Patent CA-2608671-A1 (CA)
Inventor: DANIELL HENRY
IPC: A01H1/00
Filed: 2006-05-30
Abstract: Vaccines for conferring immunity in mammals to infective pathogens are provided, as well as vectors and methods for plastid transformation of plants to produce protective antigens and vaccines for oral delivery. The vaccines are operative by parenteral administration as well. The invention also extends to the transformed plants, plant parts, and seeds and progeny thereof. The invention is applicable to monocot and dicot plants.
Patent CA-2608856-A1 (CA)
Inventor: FERNANDEZ GILBERT
IPC: E05B73/00
Filed: 2006-05-23
Abstract: Systems, methods, and apparatuses for a detacher for a security device are disclosed. The detacher (180c) includes a magnet (1820) that can be moved relative to a housing (1810) by a motor (1830). Magnet and motor are mounted inside the housing.
Patent CA-2609955-A1 (CA)
Title: Organic catalyst with enhanced enzyme compatibility
Inventor: HILER GEORGE DOUGLAS II
IPC: D06L4/40
Filed: 2005-06-17
Abstract: This invention relates to cleaning compositions comprising organic catalysts having enhanced enzyme compatibility and processes for making and using such cleaning compositions.
Patent CA-2610883-A1 (CA)
Title: Flame retardant composition exhibiting superior thermal stability and flame retarding properties and use thereof
Inventor: GOOSSENS DANIELLE F
IPC: C08L25/06
Filed: 2006-06-01
Abstract: The present invention relates to a flame retardant composition exhibiting superior thermal stability and flame retarding properties and its use thereof.